BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23265095)

  • 1. Implantation of CD133+ stem cells in patients undergoing coronary bypass surgery: IMPACT-CABG pilot trial.
    Forcillo J; Stevens LM; Mansour S; Prieto I; Salem R; Baron C; Roy DC; Larose E; Masckauchan D; Noiseux N
    Can J Cardiol; 2013 Apr; 29(4):441-7. PubMed ID: 23265095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial.
    Nasseri BA; Ebell W; Dandel M; Kukucka M; Gebker R; Doltra A; Knosalla C; Choi YH; Hetzer R; Stamm C
    Eur Heart J; 2014 May; 35(19):1263-74. PubMed ID: 24497345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies.
    Stamm C; Kleine HD; Choi YH; Dunkelmann S; Lauffs JA; Lorenzen B; David A; Liebold A; Nienaber C; Zurakowski D; Freund M; Steinhoff G
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):717-25. PubMed ID: 17320570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The IMPACT-CABG trial: A multicenter, randomized clinical trial of CD133
    Noiseux N; Mansour S; Weisel R; Stevens LM; Der Sarkissian S; Tsang K; Crean AM; Larose E; Li SH; Wintersperger B; Vu MQ; Prieto I; Li RK; Roy DC; Yau TM
    J Thorac Cardiovasc Surg; 2016 Dec; 152(6):1582-1588.e2. PubMed ID: 27665225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery.
    Klein HM; Ghodsizad A; Marktanner R; Poll L; Voelkel T; Mohammad Hasani MR; Piechaczek C; Feifel N; Stockschlaeder M; Burchardt ER; Kar BJ; Gregoric I; Gams E
    Heart Surg Forum; 2007; 10(1):E66-9. PubMed ID: 17162408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of preoperative left ventricular function and time from infarction on the long-term benefits after intramyocardial CD133(+) bone marrow stem cell transplant.
    Yerebakan C; Kaminski A; Westphal B; Donndorf P; Glass A; Liebold A; Stamm C; Steinhoff G
    J Thorac Cardiovasc Surg; 2011 Dec; 142(6):1530-9.e3. PubMed ID: 21664627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year follow-up of the local autologous transplantation of CD133+ enriched bone marrow cells in patients with myocardial infarction.
    Ahmadi H; Farahani MM; Kouhkan A; Moazzami K; Fazeli R; Sadeghian H; Namiri M; Madani-Civi M; Baharvand H; Aghdami N
    Arch Iran Med; 2012 Jan; 15(1):32-5. PubMed ID: 22208441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional recovery of patients with ischemic cardiomyopathy treated with coronary artery bypass surgery and concomitant intramyocardial bone marrow mononuclear cell implantation--a long-term follow-up study.
    Trifunović Z; Obradović S; Balint B; Ilić R; Vukić Z; Šišić M; Kostić J; Rusović S; Dobrić M; Ostojić G
    Vojnosanit Pregl; 2015 Mar; 72(3):225-32. PubMed ID: 25958473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial.
    Karantalis V; DiFede DL; Gerstenblith G; Pham S; Symes J; Zambrano JP; Fishman J; Pattany P; McNiece I; Conte J; Schulman S; Wu K; Shah A; Breton E; Davis-Sproul J; Schwarz R; Feigenbaum G; Mushtaq M; Suncion VY; Lardo AC; Borrello I; Mendizabal A; Karas TZ; Byrnes J; Lowery M; Heldman AW; Hare JM
    Circ Res; 2014 Apr; 114(8):1302-10. PubMed ID: 24565698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo visualization of 111In labeled CD133+ peripheral blood stem cells after intracoronary administration in patients with chronic ischemic heart disease.
    Caveliers V; De Keulenaer G; Everaert H; Van Riet I; Van Camp G; Verheye S; Roland J; Schoors D; Franken PR; Schots R
    Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):61-6. PubMed ID: 17372574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot study to evaluate the safety and feasibility of intracoronary CD133(+) and CD133(-) CD34(+) cell therapy in patients with nonviable anterior myocardial infarction.
    Manginas A; Goussetis E; Koutelou M; Karatasakis G; Peristeri I; Theodorakos A; Leontiadis E; Plessas N; Theodosaki M; Graphakos S; Cokkinos DV
    Catheter Cardiovasc Interv; 2007 May; 69(6):773-81. PubMed ID: 17394248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined transepicardial and transseptal implantation of autologous CD 133+ bone marrow cells during bypass grafting improves cardiac function in patients with low ejection fraction.
    Soetisna TW; Sukmawan R; Setianto B; Mansyur M; Murni TW; Listiyaningsih E; Santoso A
    J Card Surg; 2020 Apr; 35(4):740-746. PubMed ID: 32048356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety analysis and improved cardiac function following local autologous transplantation of CD133(+) enriched bone marrow cells after myocardial infarction.
    Ahmadi H; Baharvand H; Ashtiani SK; Soleimani M; Sadeghian H; Ardekani JM; Mehrjerdi NZ; Kouhkan A; Namiri M; Madani-Civi M; Fattahi F; Shahverdi A; Dizaji AV
    Curr Neurovasc Res; 2007 Aug; 4(3):153-60. PubMed ID: 17691968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Outcome of Intra-Myocardial Injection of Autologous Bone Marrow Mononuclear Cells Combined with Isolated Coronary Artery Bypass Grafting for Patients with Chronic Ischemic Heart Failure.
    Wang R; Zhang L; Wang Y; Gong Z; Xiao C; Wu Y; Ren C; Cheng N; Gao C
    Heart Surg Forum; 2016 Jun; 19(3):E131-8. PubMed ID: 27355149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical labeling and imaging of transplanted CD133+/CD34+ stem cells in patients with ischemic heart disease.
    Ghodsizad A; Bordel V; Bruckner B; Loebe M; Fuerst G; Mirsaidi I; Sucker M; Ruhparwar A; Karck M; Klein HM
    Heart Surg Forum; 2012 Apr; 15(2):E116-18. PubMed ID: 22543333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic stem-cell senescence and myocardial repair - Coronary artery disease genotype/phenotype analysis of post-MI myocardial regeneration response induced by CABG/CD133+ bone marrow hematopoietic stem cell treatment in RCT PERFECT Phase 3.
    Wolfien M; Klatt D; Salybekov AA; Ii M; Komatsu-Horii M; Gaebel R; Philippou-Massier J; Schrinner E; Akimaru H; Akimaru E; David R; Garbade J; Gummert J; Haverich A; Hennig H; Iwasaki H; Kaminski A; Kawamoto A; Klopsch C; Kowallick JT; Krebs S; Nesteruk J; Reichenspurner H; Ritter C; Stamm C; Tani-Yokoyama A; Blum H; Wolkenhauer O; Schambach A; Asahara T; Steinhoff G
    EBioMedicine; 2020 Jul; 57():102862. PubMed ID: 32629392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct minimally invasive intramyocardial injection of bone marrow-derived AC133+ stem cells in patients with refractory ischemia: preliminary results.
    Pompilio G; Steinhoff G; Liebold A; Pesce M; Alamanni F; Capogrossi MC; Biglioli P
    Thorac Cardiovasc Surg; 2008 Mar; 56(2):71-6. PubMed ID: 18278680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laser-supported CD133+ cell therapy in patients with ischemic cardiomyopathy: initial results from a prospective phase I multicenter trial.
    Assmann A; Heke M; Kröpil P; Ptok L; Hafner D; Ohmann C; Martens A; Karluβ A; Emmert MY; Kutschka I; Sievers HH; Klein HM
    PLoS One; 2014; 9(7):e101449. PubMed ID: 25000346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot trial of autologous bone marrow mononuclear cell transplantation through grafting artery: a sub-study focused on segmental left ventricular function recovery and scar reduction.
    Lu M; Liu S; Zheng Z; Yin G; Song L; Chen H; Chen X; Chen Q; Jiang S; Tian L; He Z; Hu S; Zhao S
    Int J Cardiol; 2013 Oct; 168(3):2221-7. PubMed ID: 23478196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramyocardial transplantation of mesenchymal stromal cells for chronic myocardial ischemia and impaired left ventricular function: Results of the MESAMI 1 pilot trial.
    Guijarro D; Lebrin M; Lairez O; Bourin P; Piriou N; Pozzo J; Lande G; Berry M; Le Tourneau T; Cussac D; Sensebe L; Gross F; Lamirault G; Huynh A; Manrique A; Ruidavet JB; Elbaz M; Trochu JN; Parini A; Kramer S; Galinier M; Lemarchand P; Roncalli J
    Int J Cardiol; 2016 Apr; 209():258-65. PubMed ID: 26901787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.